vs

Side-by-side financial comparison of CABOT CORP (CBT) and Wendy's Co (WEN). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $523.5M, roughly 1.6× Wendy's Co). CABOT CORP runs the higher net margin — 8.6% vs 7.5%, a 1.1% gap on every dollar of revenue. On growth, Wendy's Co posted the faster year-over-year revenue change (-3.2% vs -11.1%). Wendy's Co produced more free cash flow last quarter ($68.0M vs $57.0M). Over the past eight quarters, Wendy's Co's revenue compounded faster (-4.2% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

The Wendy's Company is an American fast food corporation and the holding company for Wendy's and First Kitchen. Originally founded as the Deisel-Wemmer Company, it is headquartered in Dublin, Ohio. The company's principal subsidiary, Wendy's International, is the franchisor of Wendy's restaurants.

CBT vs WEN — Head-to-Head

Bigger by revenue
CBT
CBT
1.6× larger
CBT
$849.0M
$523.5M
WEN
Growing faster (revenue YoY)
WEN
WEN
+7.9% gap
WEN
-3.2%
-11.1%
CBT
Higher net margin
CBT
CBT
1.1% more per $
CBT
8.6%
7.5%
WEN
More free cash flow
WEN
WEN
$11.0M more FCF
WEN
$68.0M
$57.0M
CBT
Faster 2-yr revenue CAGR
WEN
WEN
Annualised
WEN
-4.2%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q1 FY2027

Metric
CBT
CBT
WEN
WEN
Revenue
$849.0M
$523.5M
Net Profit
$73.0M
$39.2M
Gross Margin
24.9%
64.1%
Operating Margin
15.2%
15.9%
Net Margin
8.6%
7.5%
Revenue YoY
-11.1%
-3.2%
Net Profit YoY
-21.5%
72.7%
EPS (diluted)
$1.37
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
WEN
WEN
Q1 26
$523.5M
Q4 25
$849.0M
$543.0M
Q3 25
$899.0M
$549.5M
Q2 25
$923.0M
$560.9M
Q1 25
$936.0M
$523.5M
Q4 24
$955.0M
$574.3M
Q3 24
$1.0B
$566.7M
Q2 24
$1.0B
$570.7M
Net Profit
CBT
CBT
WEN
WEN
Q1 26
$39.2M
Q4 25
$73.0M
$26.5M
Q3 25
$43.0M
$44.3M
Q2 25
$101.0M
$55.1M
Q1 25
$94.0M
$39.2M
Q4 24
$93.0M
$47.5M
Q3 24
$137.0M
$50.2M
Q2 24
$109.0M
$54.6M
Gross Margin
CBT
CBT
WEN
WEN
Q1 26
64.1%
Q4 25
24.9%
62.7%
Q3 25
24.5%
62.8%
Q2 25
26.4%
65.0%
Q1 25
25.7%
64.1%
Q4 24
24.6%
65.9%
Q3 24
24.0%
65.5%
Q2 24
25.2%
65.0%
Operating Margin
CBT
CBT
WEN
WEN
Q1 26
15.9%
Q4 25
15.2%
11.8%
Q3 25
15.2%
16.8%
Q2 25
18.1%
18.6%
Q1 25
17.3%
15.9%
Q4 24
16.2%
16.7%
Q3 24
15.0%
16.7%
Q2 24
16.9%
17.4%
Net Margin
CBT
CBT
WEN
WEN
Q1 26
7.5%
Q4 25
8.6%
4.9%
Q3 25
4.8%
8.1%
Q2 25
10.9%
9.8%
Q1 25
10.0%
7.5%
Q4 24
9.7%
8.3%
Q3 24
13.7%
8.9%
Q2 24
10.7%
9.6%
EPS (diluted)
CBT
CBT
WEN
WEN
Q1 26
$0.19
Q4 25
$1.37
$0.14
Q3 25
$0.80
$0.23
Q2 25
$1.86
$0.29
Q1 25
$1.69
$0.19
Q4 24
$1.67
$0.23
Q3 24
$2.41
$0.25
Q2 24
$1.94
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
WEN
WEN
Cash + ST InvestmentsLiquidity on hand
$230.0M
$300.8M
Total DebtLower is stronger
$2.8B
Stockholders' EquityBook value
$1.6B
$117.4M
Total Assets
$3.8B
$5.0B
Debt / EquityLower = less leverage
23.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
WEN
WEN
Q1 26
$300.8M
Q4 25
$230.0M
$300.8M
Q3 25
$258.0M
$291.4M
Q2 25
$239.0M
$281.2M
Q1 25
$213.0M
$335.3M
Q4 24
$183.0M
$450.5M
Q3 24
$223.0M
$482.2M
Q2 24
$197.0M
$465.5M
Total Debt
CBT
CBT
WEN
WEN
Q1 26
$2.8B
Q4 25
$2.8B
Q3 25
$1.1B
$2.7B
Q2 25
$2.7B
Q1 25
$2.7B
Q4 24
$2.7B
Q3 24
$1.1B
Q2 24
Stockholders' Equity
CBT
CBT
WEN
WEN
Q1 26
$117.4M
Q4 25
$1.6B
$117.4M
Q3 25
$1.6B
$109.2M
Q2 25
$1.5B
$112.9M
Q1 25
$1.4B
$130.2M
Q4 24
$1.4B
$259.4M
Q3 24
$1.4B
$259.9M
Q2 24
$1.3B
$273.8M
Total Assets
CBT
CBT
WEN
WEN
Q1 26
$5.0B
Q4 25
$3.8B
$5.0B
Q3 25
$3.8B
$5.0B
Q2 25
$3.8B
$4.9B
Q1 25
$3.8B
$4.9B
Q4 24
$3.6B
$5.0B
Q3 24
$3.7B
$5.1B
Q2 24
$3.6B
$5.1B
Debt / Equity
CBT
CBT
WEN
WEN
Q1 26
23.51×
Q4 25
23.51×
Q3 25
0.70×
24.95×
Q2 25
24.18×
Q1 25
21.00×
Q4 24
10.57×
Q3 24
0.75×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
WEN
WEN
Operating Cash FlowLast quarter
$126.0M
$85.4M
Free Cash FlowOCF − Capex
$57.0M
$68.0M
FCF MarginFCF / Revenue
6.7%
13.0%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
1.73×
2.18×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$242.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
WEN
WEN
Q1 26
$85.4M
Q4 25
$126.0M
$69.3M
Q3 25
$219.0M
$129.3M
Q2 25
$249.0M
$60.6M
Q1 25
$73.0M
$85.4M
Q4 24
$124.0M
$68.6M
Q3 24
$204.0M
$141.2M
Q2 24
$207.0M
$45.5M
Free Cash Flow
CBT
CBT
WEN
WEN
Q1 26
$68.0M
Q4 25
$57.0M
$31.4M
Q3 25
$155.0M
$104.3M
Q2 25
$188.0M
$39.2M
Q1 25
$1.0M
$67.7M
Q4 24
$47.0M
$26.6M
Q3 24
$112.0M
$123.3M
Q2 24
$155.0M
$28.4M
FCF Margin
CBT
CBT
WEN
WEN
Q1 26
13.0%
Q4 25
6.7%
5.8%
Q3 25
17.2%
19.0%
Q2 25
20.4%
7.0%
Q1 25
0.1%
12.9%
Q4 24
4.9%
4.6%
Q3 24
11.2%
21.8%
Q2 24
15.3%
5.0%
Capex Intensity
CBT
CBT
WEN
WEN
Q1 26
Q4 25
8.1%
7.0%
Q3 25
7.1%
4.5%
Q2 25
6.6%
3.8%
Q1 25
7.7%
3.4%
Q4 24
8.1%
7.3%
Q3 24
9.2%
3.2%
Q2 24
5.1%
3.0%
Cash Conversion
CBT
CBT
WEN
WEN
Q1 26
2.18×
Q4 25
1.73×
2.62×
Q3 25
5.09×
2.92×
Q2 25
2.47×
1.10×
Q1 25
0.78×
2.18×
Q4 24
1.33×
1.44×
Q3 24
1.49×
2.81×
Q2 24
1.90×
0.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

WEN
WEN

Segment breakdown not available.

Related Comparisons